Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2004Large interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicityColler, J.; Krebsfaenger, N.; Klein, K.; Wolbold, R.; Nussler, A.; Neuhaus, P.; Zanger, U.; Eichelbaum, M.; Murdter, T.
2007Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipientsWestley, I.; Taylor, P.; Salm, P.; Morris, R.
2009The acceptability, safety, and tolerability of methadone/naloxone in a 50:1 ratioBell, J.; Shearer, J.; Ryan, A.; Graham, R.; Korompay, K.; Rizzo, S.; Sindhusake, D.; Somogyi, A.
2004CYP3A4 mediates dextropropoxyphene N-demethylation to nordextropropoxyphene: human in vitro and in vivo studies and lack of CYP2D6 involvementSomogyi, A.; Menelaou, A.; Fullston, S.
2001Population pharmacokinetics of lamotrigineChan, V.; Morris, R.; Ilet, K.; Tett, S.
2006A comparison of folic acid deficiency-induced genomic instability in lymphocytes of breast cancer patients and normal non-cancer controls from a Chinese population in YunnanWang, X.; Wu, X.; Liang, Z.; Huang, Y.; Fenech, M.; Xue, J.
2001Normal human lymphocytes exhibit a wide range of methionine-dependency which is related to altered cell division but not micronucleus frequencyCrott, J.; Thomas, P.; Fenech, M.
2007Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypesSchroth, W.; Antoniadou, L.; Fritz, P.; Schwab, M.; Muerdter, T.; Zanger, U.; Simon, W.; Eichelbaum, M.; Brauch, H.
2005Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal diseaseReuter, S.; Evans, A.; Faull, R.; Chace, D.; Fornasini, G.